Insulet Corporation

Company Profile

Insulet Corporation had its IPO on 2007-05-15 under the ticker symbol PODD.

The company operates in the Healthcare sector and Medical Devices industry. Insulet Corporation has a staff strength of 2,600 employees.

Stock update

Shares of Insulet Corporation opened at $174.17 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $170.19 - $177.91, and closed at $175.46.

This is a +0.11% increase from the previous day's closing price.

A total volume of 1,198,912 shares were traded at the close of the day’s session.

In the last one week, shares of Insulet Corporation have slipped by -8.7%.

Insulet Corporation's Key Ratios

Insulet Corporation has a market cap of $12.24 billion, indicating a price to book ratio of 49.0554 and a price to sales ratio of 16.7089.

In the last 12-months Insulet Corporation’s revenue was $1.47 billion with a gross profit of $805.60 million and an EBITDA of $141.70 million. The EBITDA ratio measures Insulet Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Insulet Corporation’s operating margin was 5.07% while its return on assets stood at 2.06% with a return of equity of 12.89%.

In Q2, Insulet Corporation’s quarterly earnings growth was a negative -15% while revenue growth was a positive 32.4%.

Insulet Corporation’s PE and PEG Ratio

Forward PE

256.4103

Trailing PE

203.7907

PEG

3.3234

Its diluted EPS in the last 12-months stands at $0.86 per share while it has a forward price to earnings multiple of 256.4103 and a PEG multiple of 3.3234. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Insulet Corporation’s profitability.

Insulet Corporation stock is trading at a EV to sales ratio of 17.4382 and a EV to EBITDA ratio of 178.8856. Its price to sales ratio in the trailing 12-months stood at 16.7089.

Insulet Corporation stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$2.39 billion

Total Liabilities

$425.00 million

Operating Cash Flow

$-23100000.00

Capital Expenditure

$18.10 million

Dividend Payout Ratio

0%

Insulet Corporation ended 2024 with $2.39 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $2.39 billion while shareholder equity stood at $553.90 million.

Insulet Corporation ended 2024 with $0 in deferred long-term liabilities, $425.00 million in other current liabilities, 100000.00 in common stock, $-533200000.00 in retained earnings and $51.70 million in goodwill. Its cash balance stood at $660.10 million and cash and short-term investments were $660.10 million. The company’s total short-term debt was $29,200,000 while long-term debt stood at $1.37 billion.

Insulet Corporation’s total current assets stands at $1.42 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $250.50 million compared to accounts payable of $107.50 million and inventory worth $411.30 million.

In 2024, Insulet Corporation's operating cash flow was $-23100000.00 while its capital expenditure stood at $18.10 million.

Comparatively, Insulet Corporation paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$175.46

52-Week High

$335.91

52-Week Low

$170.19

Analyst Target Price

$353.65

Insulet Corporation stock is currently trading at $175.46 per share. It touched a 52-week high of $335.91 and a 52-week low of $335.91. Analysts tracking the stock have a 12-month average target price of $353.65.

Its 50-day moving average was $239.35 and 200-day moving average was $284.76 The short ratio stood at 3.5 indicating a short percent outstanding of 0%.

Around 41.7% of the company’s stock are held by insiders while 10640.1% are held by institutions.